Manulife (Manufacturers Life Insurance)
VNDA icon

Manulife (Manufacturers Life Insurance)’s Vanda Pharmaceuticals VNDA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Sell
15,309
-2,190
-13% -$16.9K ﹤0.01% 2613
2025
Q4 		$154K Sell
17,499
-1,558
-8% -$8.57K ﹤0.01% 2615
2025
Q3 		$95.1K Sell
19,057
-1,714
-8% -$7.93K ﹤0.01% 2788
2025
Q2 		$98K Sell
20,771
-1,326
-6% -$5.8K ﹤0.01% 2762
2025
Q1 		$101K Sell
22,097
-549
-2% -$2.56K ﹤0.01% 2688
2024
Q4 		$108K Sell
22,646
-285
-1% -$1.37K ﹤0.01% 2801
2024
Q3 		$108K Sell
22,931
-657
-3% -$3.52K ﹤0.01% 2852
2024
Q2 		$133K Buy
23,588
+266
+1% +$1.37K ﹤0.01% 2745
2024
Q1 		$95.9K Hold
23,322
– – ﹤0.01% 2783
2023
Q4 		$98.4K Hold
23,322
– – ﹤0.01% 2825
2023
Q3 		$101K Hold
23,322
– – ﹤0.01% 2806
2023
Q2 		$154K Buy
23,322
+1,424
+7% +$9.13K ﹤0.01% 2704
2023
Q1 		$149K Hold
21,898
– – ﹤0.01% 2654
2022
Q4 		$162K Sell
21,898
-27
-0.1% -$263 ﹤0.01% 2654
2022
Q3 		$217K Sell
21,925
-558
-2% -$5.89K ﹤0.01% 2539
2022
Q2 		$245K Sell
22,483
-502
-2% -$5.2K ﹤0.01% 2516
2022
Q1 		$260K Sell
22,985
-5,591
-20% -$73.5K ﹤0.01% 2601
2021
Q4 		$448 Sell
28,576
-82
-0.3% -$1.43K ﹤0.01% 2337
2021
Q3 		$491K Sell
28,658
-2,802
-9% -$49.1K ﹤0.01% 2302
2021
Q2 		$677K Buy
31,460
+527
+2% +$9.43K ﹤0.01% 2228
2021
Q1 		$465K Sell
30,933
-2,238
-7% -$36.2K ﹤0.01% 2327
2020
Q4 		$436K Buy
33,171
+890
+3% +$10.7K ﹤0.01% 2284
2020
Q3 		$312K Hold
32,281
– – ﹤0.01% 2272
2020
Q2 		$362K Sell
32,281
-1,582
-5% -$17.9K ﹤0.01% 2128
2020
Q1 		$351K Buy
33,863
+2,258
+7% +$28K ﹤0.01% 2006
2019
Q4 		$519K Sell
31,605
-1,081
-3% -$16.3K ﹤0.01% 2029
2019
Q3 		$445K Hold
32,686
– – ﹤0.01% 2093
2019
Q2 		$461K Sell
32,686
-123,599
-79% -$1.97M ﹤0.01% 2099
2019
Q1 		$2.88M Buy
156,285
+124,454
+391% +$2.84M ﹤0.01% 1345
2018
Q4 		$832K Sell
31,831
-1,631
-5% -$38.3K ﹤0.01% 1668
2018
Q3 		$768K Sell
33,462
-5,011
-13% -$102K ﹤0.01% 1968
2018
Q2 		$732K Buy
38,473
+5,162
+15% +$86.3K ﹤0.01% 2086
2018
Q1 		$562K Sell
33,311
-887
-3% -$14.8K ﹤0.01% 2247
2017
Q4 		$519K Buy
34,198
+389
+1% +$5.77K ﹤0.01% 2297
2017
Q3 		$605K Sell
33,809
-1,073
-3% -$18K ﹤0.01% 2134
2017
Q2 		$568K Buy
34,882
+5,875
+20% +$84.7K ﹤0.01% 2194
2017
Q1 		$405K Buy
29,007
+3,737
+15% +$53.3K ﹤0.01% 2337
2016
Q4 		$403K Sell
25,270
-657
-3% -$10.6K ﹤0.01% 2261
2016
Q3 		$431K Sell
25,927
-527
-2% -$7.09K ﹤0.01% 2171
2016
Q2 		$296K Sell
26,454
-2,003
-7% -$19.4K ﹤0.01% 2401
2016
Q1 		$229K Sell
28,457
-15
-0.1% -$123 ﹤0.01% 2510
2015
Q4 		$265 Buy
28,472
+295
+1% +$2.94K ﹤0.01% 2445
2015
Q3 		$318 Buy
28,177
+652
+2% +$7.97K ﹤0.01% 2294
2015
Q2 		$349 Buy
27,525
+939
+4% +$10.1K ﹤0.01% 2385
2015
Q1 		$248 Buy
26,586
+3,039
+13% +$34.3K ﹤0.01% 2572
2014
Q4 		$337 Buy
23,547
+1,191
+5% +$14.1K ﹤0.01% 2259
2014
Q3 		$232 Buy
22,356
+522
+2% +$6.84K ﹤0.01% 2540
2014
Q2 		$353K Sell
21,834
-3,451
-14% -$46K ﹤0.01% 2302
2014
Q1 		$411 Sell
25,285
-480
-2% -$6.82K ﹤0.01% 2216
2013
Q4 		$320 Buy
25,765
+3,408
+15% +$34.2K ﹤0.01% 2368
2013
Q3 		$245 Buy
22,357
+102
+0.5% +$1.09K ﹤0.01% 2500
2013
Q2 		$180K Buy
+22,255
New +$150K ﹤0.01% 2655

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s VNDA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Vanda Pharmaceuticals (VNDA) stake by 13% in Q1 2026, selling an estimated $16.9K and leaving 15,309 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #2613.

Manulife (Manufacturers Life Insurance) first reported a position in VNDA in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.88M in Q1 2019. 171 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 15,309 shares of Vanda Pharmaceuticals worth $106K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,190 Vanda Pharmaceuticals shares in Q1 2026, an estimated $16.9K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2613 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Vanda Pharmaceuticals position peaked at $2.88M in Q1 2019.
  • 171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.